|
TPM4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.376500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.88590000000422E-05 |
| Normal-vs-Stage2 |
3.173800E-04 |
| Normal-vs-Stage3 |
6.690500E-02 |
| Normal-vs-Stage4 |
7.520000E-02 |
| Stage1-vs-Stage2 |
8.325400E-01 |
| Stage1-vs-Stage3 |
3.116300E-03 |
| Stage1-vs-Stage4 |
2.608200E-01 |
| Stage2-vs-Stage3 |
3.468300E-02 |
| Stage2-vs-Stage4 |
3.248600E-01 |
| Stage3-vs-Stage4 |
4.807400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.561750E-04 |
| Normal-vs-AfricanAmerican |
7.649600E-04 |
| Normal-vs-Asian |
6.3095000000013E-05 |
| Caucasian-vs-AfricanAmerican |
3.953600E-01 |
| Caucasian-vs-Asian |
3.835600E-01 |
| AfricanAmerican-vs-Asian |
1.436790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.71970000000843E-05 |
| Normal-vs-Female |
4.364800E-03 |
| Male-vs-Female |
8.236600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.043800E-04 |
| Normal-vs-Extreme_Weight |
1.164100E-04 |
| Normal-vs-Obese |
2.161800E-03 |
| Normal-vs-Extreme_Obese |
4.62260000000381E-06 |
| Normal_Weight-vs-Extreme_Weight |
5.994200E-01 |
| Normal_Weight-vs-Obese |
4.105800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.035900E-02 |
| Extreme_Weight-vs-Obese |
1.374960E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.417700E-02 |
| Obese-vs-Extreme_Obese |
7.203600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.945900E-02 |
| Normal-vs-Age(41-60Yrs) |
7.990000E-04 |
| Normal-vs-Age(61-80Yrs) |
7.90999999999986E-05 |
| Normal-vs-Age(81-100Yrs) |
3.91360000000507E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.934200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.292000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.843800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.059700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.419500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.143800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.41909999999912E-05 |
| Normal-VS-Type2 PRCC |
5.93660000000051E-05 |
| Normal-VS-KIRP CIMP |
9.672400E-01 |
| Normal-VS-Unclassified PRCC |
1.069780E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.194200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.2934999999169E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
1.254210E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.92160999999968E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.080600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.035900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.80256999999795E-05 |
| Normal-vs-N1 |
1.896390E-01 |
| Normal-vs-N2 |
7.314000E-01 |
| N0-vs-N1 |
1.078000E-03 |
| N0-vs-N2 |
1.52976999999721E-05 |
| N1-vs-N2 |
2.106800E-01 |
|
|
